This site is intended for healthcare professionals
Respiratory Care

Inhaled Management of COPD

In this section, we detail the current guidelines for COPD and the different treatment options available. This section of the Learning Zone also includes specific information on treating women with COPD.

Treatment options

This section of the Learning Zone aims to provide you with information to help you decide which treatments options are suitable for your patients. Topics include:

  • Goals of treatment
  • Non-pharmacological intervention options
  • Pharmacological intervention options
  • Bronchodilators
  • Muscarinic antagonists
  • β2-agonists
  • Methylxanthines
  • Bronchodilator combinations
  • Anti-inflammatory drugs
  • Triple therapy
  • Advantages of 24-hour duration of action and once-daily dosing
Register free for full access to


Global initiative for chronic Obstructive Lung Disease

The latest recommendations from GOLD are available from the GOLD website.

Since its first annual report in 1997, the Global initiative for chronic Obstructive Lung Disease (GOLD) has sought to provide recommendations for the management of COPD based on the best scientific information available. Its aim has been a non-biased review for the practising clinician to aid in the assessment, diagnosis and treatment of patients with COPD. 

Register free for full access to

Considerations in Women

This section within COPD and its Management aims to provide information surrounding the management of COPD in women.

COPD is a highly debilitating disease that represents a substantial and growing health burden in women1. Despite this burden, COPD receives scant attention as a women’s health issue1

Register free for full access to

Treatment options references

  1. Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2020. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease.; 2020. Accessed November 25, 2019.
  2. Kuyucu T, Güçlü SZ, ┼×aylan B, et al. A cross-sectional observational study to investigate daily symptom variability, effects of symptom on morning activities and therapeutic expectations of patients and physicians in COPD-SUNRISE study. Tuberc Thorax. 2011;59(4):328-339.

Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society Statement on Pulmonary Rehabilitation. Am J Respir Crit Care Med. 2006;173(12):1390-1413.

Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest. 2007;131(5 SUPPL.):4S-42S.

Register free for full access to